Cambridge Investment Research Advisors Inc. grew its stake in shares of Oracle Corporation (NYSE:ORCL - Free Report) by 2.8% during the 1st quarter, according to the company in its most recent disclosure with the Securities and Exchange Commission (SEC). The institutional investor owned 232,457 shares of the enterprise software provider's stock after acquiring an additional 6,231 shares during the period. Cambridge Investment Research Advisors Inc.'s holdings in Oracle were worth $32,500,000 at the end of the most recent reporting period.
A number of other large investors have also recently made changes to their positions in ORCL. Cookson Peirce & Co. Inc. raised its stake in Oracle by 4.4% during the 4th quarter. Cookson Peirce & Co. Inc. now owns 1,423 shares of the enterprise software provider's stock worth $237,000 after acquiring an additional 60 shares during the period. New England Capital Financial Advisors LLC boosted its position in shares of Oracle by 6.4% in the fourth quarter. New England Capital Financial Advisors LLC now owns 1,061 shares of the enterprise software provider's stock worth $177,000 after purchasing an additional 64 shares during the period. Cape ANN Savings Bank increased its stake in shares of Oracle by 1.1% in the fourth quarter. Cape ANN Savings Bank now owns 5,820 shares of the enterprise software provider's stock worth $970,000 after purchasing an additional 65 shares in the last quarter. Greenwood Gearhart Inc. increased its stake in shares of Oracle by 1.2% in the fourth quarter. Greenwood Gearhart Inc. now owns 5,731 shares of the enterprise software provider's stock worth $955,000 after purchasing an additional 66 shares in the last quarter. Finally, WorthPointe LLC raised its position in shares of Oracle by 4.0% during the 4th quarter. WorthPointe LLC now owns 1,734 shares of the enterprise software provider's stock valued at $289,000 after purchasing an additional 67 shares during the period. 42.44% of the stock is owned by institutional investors.
Oracle Trading Down 2.8%
Shares of ORCL stock opened at $205.06 on Monday. The company has a market cap of $575.96 billion, a PE ratio of 47.25, a price-to-earnings-growth ratio of 3.08 and a beta of 1.32. Oracle Corporation has a 1 year low of $118.86 and a 1 year high of $216.60. The stock's 50 day simple moving average is $160.39 and its two-hundred day simple moving average is $161.16. The company has a debt-to-equity ratio of 4.07, a current ratio of 0.75 and a quick ratio of 0.75.
Oracle (NYSE:ORCL - Get Free Report) last released its quarterly earnings results on Wednesday, June 11th. The enterprise software provider reported $1.70 earnings per share for the quarter, beating the consensus estimate of $1.64 by $0.06. The company had revenue of $15.90 billion for the quarter, compared to analyst estimates of $15.58 billion. Oracle had a return on equity of 87.34% and a net margin of 21.68%. Oracle's quarterly revenue was up 11.3% compared to the same quarter last year. During the same quarter in the prior year, the firm posted $1.63 EPS. Research analysts predict that Oracle Corporation will post 5 earnings per share for the current year.
Oracle Announces Dividend
The company also recently announced a quarterly dividend, which will be paid on Thursday, July 24th. Stockholders of record on Thursday, July 10th will be issued a $0.50 dividend. The ex-dividend date of this dividend is Thursday, July 10th. This represents a $2.00 annualized dividend and a dividend yield of 0.98%. Oracle's dividend payout ratio (DPR) is presently 46.08%.
Analysts Set New Price Targets
Several research analysts recently weighed in on ORCL shares. Barclays reaffirmed an "overweight" rating and issued a $221.00 target price (up previously from $202.00) on shares of Oracle in a report on Friday, June 13th. CIBC restated a "buy" rating on shares of Oracle in a research report on Monday, June 9th. DA Davidson upped their price objective on Oracle from $140.00 to $170.00 and gave the stock a "neutral" rating in a research note on Thursday, June 12th. Piper Sandler reissued a "neutral" rating and set a $130.00 target price on shares of Oracle in a research note on Wednesday, June 11th. Finally, Cantor Fitzgerald lowered their price target on Oracle from $214.00 to $175.00 and set an "overweight" rating on the stock in a report on Tuesday, March 11th. Eleven equities research analysts have rated the stock with a hold rating, twenty-one have assigned a buy rating and two have given a strong buy rating to the company's stock. Based on data from MarketBeat.com, the stock presently has a consensus rating of "Moderate Buy" and a consensus price target of $196.74.
View Our Latest Research Report on Oracle
Insider Buying and Selling
In other Oracle news, Vice Chairman Jeffrey Henley sold 400,000 shares of the company's stock in a transaction on Thursday, June 12th. The stock was sold at an average price of $190.42, for a total value of $76,168,000.00. Following the transaction, the insider now owns 1,097,576 shares of the company's stock, valued at $209,000,421.92. This represents a 26.71% decrease in their position. The sale was disclosed in a legal filing with the SEC, which is available through this hyperlink. Also, insider Clayton M. Magouyrk sold 15,000 shares of the stock in a transaction on Tuesday, June 17th. The stock was sold at an average price of $214.10, for a total value of $3,211,500.00. Following the completion of the sale, the insider now owns 60,722 shares in the company, valued at approximately $13,000,580.20. The trade was a 19.81% decrease in their position. The disclosure for this sale can be found here. In the last ninety days, insiders sold 442,366 shares of company stock valued at $83,395,223. Company insiders own 42.20% of the company's stock.
Oracle Company Profile
(
Free Report)
Oracle Corporation offers products and services that address enterprise information technology environments worldwide. Its Oracle cloud software as a service offering include various cloud software applications, including Oracle Fusion cloud enterprise resource planning (ERP), Oracle Fusion cloud enterprise performance management, Oracle Fusion cloud supply chain and manufacturing management, Oracle Fusion cloud human capital management, Oracle Cerner healthcare, Oracle Advertising, and NetSuite applications suite, as well as Oracle Fusion Sales, Service, and Marketing.
Featured Stories

This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest and most accurate reporting. This story was reviewed by MarketBeat's editorial team prior to publication. Please send any questions or comments about this story to contact@marketbeat.com.
Before you consider Oracle, you'll want to hear this.
MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Oracle wasn't on the list.
While Oracle currently has a Moderate Buy rating among analysts, top-rated analysts believe these five stocks are better buys.
View The Five Stocks Here
Unlock your free copy of MarketBeat's comprehensive guide to pot stock investing and discover which cannabis companies are poised for growth. Plus, you'll get exclusive access to our daily newsletter with expert stock recommendations from Wall Street's top analysts.
Get This Free Report
Like this article? Share it with a colleague.
Link copied to clipboard.